Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares hit a new 52-week low during trading on Monday . The company traded as low as C$0.09 and last traded at C$0.09, with a volume of 4705 shares traded. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 6.05, a current ratio of 0.18 and a quick ratio of 0.84. The business has a 50-day simple moving average of C$0.11 and a 200 day simple moving average of C$0.14. The firm has a market cap of C$16.15 million, a PE ratio of -9.00 and a beta of 1.07.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
